Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Courtney V Fletcher

Showing results (61-70 of 162) with videos related to

Pageof 17
Sort By:
Journal of Clinical Pharmacology|May 12, 2011
The pharmacogenetics of NAT2 enzyme maturation in perinatally HIV exposed infants receiving isoniazidRui Zhu, Jennifer J Kiser, Heiner I Seifart, et al.
AIDS (London, England)|March 2, 2002
Concentration-controlled compared with conventional antiretroviral therapy for HIV infectionCourtney V Fletcher, Peter L Anderson, Thomas N Kakuda, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 16, 2021
Safety and Pharmacokinetics of Double-Dose Lopinavir/Ritonavir + Rifampin Versus Lopinavir/Ritonavir + Daily Rifabutin for Treatment of Human Immunodeficiency Virus-Tuberculosis CoinfectionMichelle A Kendall, Umesh Lalloo, Courtney V Fletcher, et al.
HIV Clinical Trials|May 18, 2007
Non-nucleoside phenotypic hypersusceptibility cut-point determination from ACTG 359Richard H Haubrich, Hongyu Jiang, Ronald Swanstrom, et al.
AIDS (London, England)|January 26, 2026
A novel measure of antiretroviral activity in CSF and association with HIV persistence and cognitive functionSean N Avedissian, Caitlyn McCarthy, Ronald J Bosch, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 21, 2021
Antiretroviral Drug Transporters and Metabolic Enzymes in Circulating Monocytes and Monocyte-Derived Macrophages of ART-Treated People Living With HIV and HIV-Uninfected IndividualsTozammel M D Hoque, Amélie Cattin, Sana-Kay Whyte-Allman, et al.
Clinical Pharmacology and Therapeutics|May 10, 2020
The Lymphoid Tissue Pharmacokinetics of Tenofovir Disoproxil Fumarate and Tenofovir Alafenamide in HIV-Infected PersonsCourtney V Fletcher, Anthony T Podany, Ann Thorkelson, et al.
Scientific Reports|February 28, 2018
Normalization of cell associated antiretroviral drug concentrations with a novel RPP30 droplet digital PCR assayShetty Ravi Dyavar, Zhen Ye, Siddappa N Byrareddy, et al.
AIDS (London, England)|September 22, 2007
The use of beta-D-2,6-diaminopurine dioxolane with or without mycophenolate mofetil in drug-resistant HIV infectionDavid M Margolis, A Lisa Mukherjee, Courtney V Fletcher, et al.
AIDS (London, England)|January 16, 2018
Plasma and intracellular pharmacokinetics of tenofovir in patients switched from tenofovir disoproxil fumarate to tenofovir alafenamideAnthony T Podany, Sara H Bares, Joshua Havens, et al.
Pageof 17

Showing results (61-70 of 162) with videos related to

Sort By:
Pageof 17
Journal of Clinical Pharmacology|May 12, 2011
The pharmacogenetics of NAT2 enzyme maturation in perinatally HIV exposed infants receiving isoniazidRui Zhu, Jennifer J Kiser, Heiner I Seifart, et al.
AIDS (London, England)|March 2, 2002
Concentration-controlled compared with conventional antiretroviral therapy for HIV infectionCourtney V Fletcher, Peter L Anderson, Thomas N Kakuda, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 16, 2021
Safety and Pharmacokinetics of Double-Dose Lopinavir/Ritonavir + Rifampin Versus Lopinavir/Ritonavir + Daily Rifabutin for Treatment of Human Immunodeficiency Virus-Tuberculosis CoinfectionMichelle A Kendall, Umesh Lalloo, Courtney V Fletcher, et al.
HIV Clinical Trials|May 18, 2007
Non-nucleoside phenotypic hypersusceptibility cut-point determination from ACTG 359Richard H Haubrich, Hongyu Jiang, Ronald Swanstrom, et al.
AIDS (London, England)|January 26, 2026
A novel measure of antiretroviral activity in CSF and association with HIV persistence and cognitive functionSean N Avedissian, Caitlyn McCarthy, Ronald J Bosch, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 21, 2021
Antiretroviral Drug Transporters and Metabolic Enzymes in Circulating Monocytes and Monocyte-Derived Macrophages of ART-Treated People Living With HIV and HIV-Uninfected IndividualsTozammel M D Hoque, Amélie Cattin, Sana-Kay Whyte-Allman, et al.
Clinical Pharmacology and Therapeutics|May 10, 2020
The Lymphoid Tissue Pharmacokinetics of Tenofovir Disoproxil Fumarate and Tenofovir Alafenamide in HIV-Infected PersonsCourtney V Fletcher, Anthony T Podany, Ann Thorkelson, et al.
Scientific Reports|February 28, 2018
Normalization of cell associated antiretroviral drug concentrations with a novel RPP30 droplet digital PCR assayShetty Ravi Dyavar, Zhen Ye, Siddappa N Byrareddy, et al.
AIDS (London, England)|September 22, 2007
The use of beta-D-2,6-diaminopurine dioxolane with or without mycophenolate mofetil in drug-resistant HIV infectionDavid M Margolis, A Lisa Mukherjee, Courtney V Fletcher, et al.
AIDS (London, England)|January 16, 2018
Plasma and intracellular pharmacokinetics of tenofovir in patients switched from tenofovir disoproxil fumarate to tenofovir alafenamideAnthony T Podany, Sara H Bares, Joshua Havens, et al.
Pageof 17